Portola Pharmaceuticals (PTLA) Rating Increased to Sell at BidaskClub

Adjust Comment Print

Rothschild Investment Corp IL now owns 24,740 shares of the biopharmaceutical company's stock worth $562,000 after buying an additional 2,590 shares in the last quarter. Jacobs Levy Equity Incorporated stated it has 0.01% in Portola Pharmaceuticals, Inc. The stock has a market cap of $3,083.14, a price-to-earnings ratio of -11.27 and a beta of 1.21. During the same period in the prior year, the firm earned ($1.23) earnings per share. It has outperformed by 34.47% the S&P500.

Moreno Evelyn V increased its stake in Intel Corp (INTC) by 5.23% based on its latest 2017Q3 regulatory filing with the SEC. Fernwood Investment Management Llc sold 9,300 shares as the company's stock rose 22.73% with the market. The hedge fund run by Christopher Medlock James held 5.08 million shares of the health care company at the end of 2017Q3, valued at $274.37M, up from 2.75M at the end of the previous reported quarter. Parus Finance Uk Ltd who had been investing in Ctrip Com Intl Ltd for a number of months, seems to be bullish on the $23.09B market cap company. The stock decreased 0.13% or $0.06 during the last trading session, reaching $46.16. The volume of 4.53 Million shares climbed down over an trading activity of 5.75 Million shares. Oppenheimer set a $80.00 price objective on Portola Pharmaceuticals and gave the stock a buy rating in a research report on Tuesday, December 19th. It has underperformed by 9.74% the S&P500.

Since December 15, 2017, it had 0 buys, and 1 insider sale for $563,950 activity. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the stock. Therefore 40% are positive. Oppenheimer reissued a "buy" rating and issued a $80.00 target price on shares of Portola Pharmaceuticals in a research report on Wednesday, September 6th. The stock now has a consensus rating of "Buy" and a consensus price target of $70.65. The rating was maintained by Citigroup on Wednesday, August 10 with "Buy". Cowen & Co maintained the stock with "Buy" rating in Monday, June 26 report. The stock has an average rating of "Buy" and a consensus target price of $70.65. The company was maintained on Wednesday, September 20 by Credit Suisse. The stock of Portola Pharmaceuticals, Inc. They set a "buy" rating and a $75.00 target price for the company. The company was maintained on Friday, October 6 by Morgan Stanley. The company was upgraded on Thursday, August 24 by Credit Suisse. Oppenheimer maintained The Home Depot, Inc. Balyasny Asset Management Limited Com, Illinois-based fund reported 5,300 shares. It also reduced its holding in Voyager Therapeutics Inc by 455,202 shares in the quarter, leaving it with 397,923 shares, and cut its stake in Clovis Oncology Inc (Prn). The stock decreased 1.45% or $0.65 during the last trading session, reaching $44.1. It is positive, as 20 investors sold PTLA shares while 37 reduced holdings. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Portola Pharmaceuticals by 14.2% during the 2nd quarter. Creative Planning accumulated 0.19% or 254,787 shares. (NASDAQ:PTLA). Renaissance Tech Limited Liability Com, a New York-based fund reported 528,500 shares. Pinnacle Associate Limited has 492,381 shares. Voya Investment Management Ltd Limited Liability Company holds 278,444 shares or 0.03% of its portfolio.

Blair William & Company, which manages about $13.34B US Long portfolio, decreased its stake in Bottomline Technologies (De) (NASDAQ:EPAY) by 25,810 shares to 145,566 shares, valued at $4.63 million in 2017Q3, according to the filing. Jpmorgan Chase has 744,702 shares.

IAG closing in on Niki purchase
Niki Lauda, former Formula One driver and a three-time F1 World Drivers' Champion, founded the airline in 2003. Lauda made a bid to buy Niki back after hearing about the insolvency, but eventually lost out to IAG.

What Historical Figures Say About Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) or 5.08 million shares. The stock of Portola Pharmaceuticals, Inc. Nicholas Invest Prns LP holds 0.24% or 64,005 shares in its portfolio. First Quadrant LP Ca has 947 shares. Endurant Capital Management LP reported 1.64% stake.

Investors sentiment increased to 1.14 in 2017 Q3. 22 funds opened positions while 44 raised stakes. Duncker Streett & Incorporated owns 0.81% invested in The Home Depot, Inc. Moreover, Pnc Group has 0% invested in Portola Pharmaceuticals, Inc. Ameriprise has invested 0% in HealthStream, Inc. Goelzer Inv Management holds 1,752 shares or 0.03% of its portfolio. Stonebridge Capital Ltd Limited Liability Company holds 55,188 shares or 2.22% of its portfolio. Metropolitan Life Insur Comm Ny invested in 17,224 shares. (NYSE:HD) for 16,455 shares. Gabelli Funds Limited Liability reported 205,600 shares. Tarbox Family Office Inc invested 0.03% in Intel Corporation (NASDAQ:INTC). C Gp Holding A S reported 0.09% stake. D E Shaw And Communications stated it has 0% in Cohen & Steers, Inc. Finally, Citigroup restated a "buy" rating and issued a $74.00 target price on shares of Portola Pharmaceuticals in a research note on Thursday. Intel Corporation had 200 analyst reports since August 7, 2015 according to SRatingsIntel. The company was upgraded on Friday, February 19 by CLSA. (NYSE:CNS) has "Hold" rating given on Sunday, August 27 by Keefe Bruyette & Woods. The company was initiated on Friday, December 1 by Goldman Sachs. The rating was downgraded by Credit Suisse to "Neutral" on Tuesday, May 31. The stock has "Sector Perform" rating by RBC Capital Markets on Monday, January 18. The firm has "Hold" rating given on Thursday, October 19 by Keefe Bruyette & Woods. As per Monday, October 31, the company rating was downgraded by PiperJaffray. (NYSE:CNS) earned "Buy" rating by Bank of America on Tuesday, March 15. The firm has "Neutral" rating given on Monday, March 28 by Goldman Sachs.

Analysts await Cohen & Steers, Inc.